Literature DB >> 17378933

Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods.

J C Palomino1, A Martin, F Portaels.   

Abstract

Several new methods to detect drug resistance in Mycobacterium tuberculosis have been proposed in recent years. Colourimetric methods that use redox indicators or the nitrate reduction assay have received increasing attention because of their simplicity and the absence of any requirement for sophisticated equipment or highly trained personnel. Several studies have evaluated their accuracy and performance in comparison with reference standard methods, particularly for the detection of resistance to rifampicin and isoniazid, which are the two most important drugs used for the treatment of tuberculosis. This review describes the development, evaluation and implementation of these methods as rapid alternative tests for the detection of multidrug resistance in M. tuberculosis. Based on published evidence and the high accuracy of colourimetric methods for detecting drug resistance in M. tuberculosis, these methods seem to be appropriate for implementation in high-burden low-resource countries.

Entities:  

Mesh:

Year:  2007        PMID: 17378933     DOI: 10.1111/j.1469-0691.2007.01698.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings.

Authors:  Yap Boum; Patrick Orikiriza; Gabriel Rojas-Ponce; Margarita Riera-Montes; Daniel Atwine; Margaret Nansumba; Joel Bazira; Eleanor Tuyakira; Pierre De Beaudrap; Maryline Bonnet; Anne-Laure Page
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

2.  Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the malachite green decolourisation assay.

Authors:  Ahmet Yilmaz Coban; Meltem Uzun
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

Review 3.  Advances in Diagnostic Assays for Tuberculosis.

Authors:  Stephen D Lawn
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

Review 4.  Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.

Authors:  Sheela Shenoi; Scott Heysell; Anthony Moll; Gerald Friedland
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

5.  Programmatic implementation of rapid DST for Mycobacterium tuberculosis in Peru.

Authors:  L Asencios; G Yale; M Yagui; N Quispe; A Taylor; J Blaya; C Contreras; P Cegielski; J Bayona; C Bonilla; S Shin
Journal:  Int J Tuberc Lung Dis       Date:  2008-07       Impact factor: 2.373

6.  Dual colorimetric and luminescent assay for dipicolinate, a biomarker of bacterial spores.

Authors:  Kasey J Clear; Sarah Stroud; Bradley D Smith
Journal:  Analyst       Date:  2013-10-08       Impact factor: 4.616

Review 7.  Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.

Authors:  Louis Grandjean; David A J Moore
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

8.  Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.

Authors:  Saif Eddine Djemal; Cristina Camperio; Federica Armas; Mariam Siala; Salma Smaoui; Feriele Messadi-Akrout; Radhouane Gdoura; Cinzia Marianelli
Journal:  BMC Vet Res       Date:  2018-09-29       Impact factor: 2.741

9.  Evaluation of four colourimetric susceptibility tests for the rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates.

Authors:  Ahmet Yilmaz Coban; Ahmet Ugur Akbal; Meltem Uzun; Belma Durupinar
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-24       Impact factor: 2.743

10.  In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA).

Authors:  Junie B Billones; Maria Constancia O Carrillo; Voltaire G Organo; Jamie Bernadette A Sy; Nina Abigail B Clavio; Stephani Joy Y Macalino; Inno A Emnacen; Alexandra P Lee; Paul Kenny L Ko; Gisela P Concepcion
Journal:  Drug Des Devel Ther       Date:  2017-03-02       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.